Strategic Partnership Opportunity to leverage the recent Biocare Medical distribution partnership to co-sell or co-market integrated digital pathology workflows, expanding reach in immunohistochemistry and in situ hybridization segments.

Product Expansion Advise targeting upgrade cycles around the iO:M8 Digital Live Microscope and upcoming fluorescence platform, highlighting how CE-IVD certified, high-precision imaging can improve intraoperative and diagnostic accuracy for hospitals and pathology labs.

Geographic Reach Capitalize on Germany-based engineering credibility and international quality standards to pursue international laboratories seeking compliant, scalable digital pathology solutions, especially in EU markets with strong regulatory alignment.

Academic & HCP Demand Position as a cost-efficient, compact digital pathology solution for teaching hospitals, research centers, and ambulatory surgical centers seeking faster biopsy review, intraoperative consultation, and streamlined image management.

Growth & Funding Signals Leverage Series A funding and recognition as Top Employer and Innovator to support outreach campaigns focused on modernizing pathology workflows, offering demos, ROI-focused pilots, and case studies to drive adoption.